A study assesses whether the dual sodium–glucose co-transporter (SGLT) 1/2 inhibitor sotagliflozin reduces ischemic events in diabetes and kidney disease.
A new analysis found that acute anemia in patients who had a heart attack is associated with a higher risk of death or recurrent myocardial infarction at 30 days.
The US Preventive Services Task Force assessed the benefits and harms of osteoporosis screening in adults aged 40 years or older without a known diagnosis of osteoporosis or history of fragility fractures.
...
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
Acoramidis, an oral therapy, is now approved to reduce cardiovascular-related deaths and hospitalizations in adults with hereditary or wild-type ATTR-CM.
Plozasiran, a first-in-class RNA interference therapeutic, reduced triglycerides by 80% and lowered the risk of acute pancreatitis by 83% in patients with familial chylomicronemia syndrome, earning FDA...
In a study that assessed pericoronary adipose tissue (PCAT) density, researchers noted an association between higher PCAT density and greater coronary plaque burden and cardiovascular disease in people with...
A recent study found that non-dihydropyridine calcium channel blockers are associated with significantly less bradycardia during sinus rhythm compared with beta-blockers in patients with non-permanent...
